Abstract Objective To investigate the myocardial protective effect of L-carnitine in children with hand, foot and mouth disease (HFMD) caused by Coxsackie A16 virus and possible mechanisms.Methods A total of 60 HFMD children with abnormal myocardial enzyme after Coxsackie A16 virus infection were enrolled and randomly divided into L-carnitine group and fructose-1,6-diphosphate group (fructose group), with 30 children in each group. The two groups were given L-carnitine or fructose diphosphate in addition to antiviral and heat clearance treatment. Another 30 healthy children who underwent physical examination were enrolled as control group. The changes in myocardial zymogram, malondialdehyde (MDA), superoxide dismutase (SOD), and apoptosis factors sFas and sFasL after treatment were compared between groups.Results There was no significant difference in treatment response between the L-carnitine group and the fructose group (P > 0.05). One child in the fructose group progressed to critical HFMD, which was not observed in the L-carnitine group. Before treatment, the L-carnitine group and the fructose group had significantly higher indices of myocardial zymogram and levels of MDA, sFas, and sFasL and a significantly lower level of SOD than the control group (P < 0.05), while there were no significant differences in these indices between the L-carnitine group and the fructose group (P > 0.05). After treatment, the L-carnitine group and the fructose group had significant reductions in the indices of myocardial zymogram and levels of MDA, sFas, and sFasL and a significant increase in the level of SOD (P < 0.05); the fructose group had a significantly higher level of creatine kinase (CK) than the control group and the L-carnitine group, and there were no significant differences in other myocardial enzyme indices, MDA, sFas, and sFasL between the L-carnitine group and the fructose group, as well as between the L-carnitine and fructose groups and the control group (P > 0.05). SOD level was negatively correlated with aspartate aminotransferase, lactate dehydrogenase (LDH), CK, and creatine kinase-MB (CK-MB) (r=-0.437, -0.364, -0.397, and -0.519 respectively; P < 0.05), and MDA level was positively correlated with LDH and CK-MB (r=0.382 and 0.411 respectively; P < 0.05).Conclusions L-carnitine exerts a good myocardial protective effect in children with HFMD caused by Coxsackie A16 virus, possibly by clearing oxygen radicals and inhibiting cardiomyocyte apoptosis.
About author:: 10.7499/j.issn.1008-8830.2017.08.012
Cite this article:
CUI Ya-Jie,SONG Chun-Lan,CHEN Fang et al. Myocardial protective effect of L-carnitine in children with hand, foot and mouth disease caused by Coxsackie A16 virus[J]. CJCP, 2017, 19(8): 908-912.
CUI Ya-Jie,SONG Chun-Lan,CHEN Fang et al. Myocardial protective effect of L-carnitine in children with hand, foot and mouth disease caused by Coxsackie A16 virus[J]. CJCP, 2017, 19(8): 908-912.
Huang X, Wei H, Wu S, et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008-2013[J]. Sci Rep, 2015, 5: 8904.
[2]
Liu SL, Pan H, Liu P, et al. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014[J]. Rev Med Virol, 2015, 25 (2): 115-128.
Yajima T. Viral myocarditis: potential defense mechanisms within the cardiomyocyte against virus infection[J]. Future Microbiol, 2011, 6 (5): 551-566.
[14]
Tada Y, Suzuki J. Oxidative stress and myocarditis[J]. Curr Pharm Des, 2016, 22 (4): 450-471.
[15]
Huang TF, Wu XH, Wang X, et al. Fas-FasL expression and myocardial cell apoptosis in patients with viral myocarditis[J]. Genet Mol Res, 2016, 15 (2): gmr.15027607.
[16]
Campos JC, Gomes KM, Ferreira JC. Impact of exercise training on redox signaling in cardiovascular diseases[J]. Food Chem Toxicol, 2013, 62: 107-119.
[17]
Tsikas D. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges[J]. Anal Biochem, 2017, 524: 13-30.
Pekala J, Patkowska-Sokoła B, Bodkowski R, et al. L-carnitine--metabolic functions and meaning in humans life[J]. Curr Drug Metab, 2011, 12 (7): 667-678.
